Home
Mail
News
Sports
Finance
Celebrity
Style
Movies
Weather
Mobile
Yahoo
Mail
News
Taxes
Watchlists
My Portfolio
My Screeners
Market Data
Industry News
Real Estate
Technology
Currency Converter
Canada markets closed
S&P/TSX
22,308.93
-66.90
(-0.30%)
S&P 500
5,222.68
+8.60
(+0.16%)
DOW
39,512.84
+125.08
(+0.32%)
CAD/USD
0.7317
+0.0006
(+0.08%)
CRUDE OIL
78.20
-1.06
(-1.34%)
Bitcoin CAD
83,606.27
+494.75
(+0.60%)
Adaptive Biotechnologies Corporation (ADPT)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.5000
-0.0600
(-1.69%)
At close: 04:00PM EDT
3.4700
-0.03
(-0.86%)
After hours:
07:01PM EDT
Summary
Chart
Conversations
Statistics
Historical Data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly
Income Statement
All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
174,502
170,276
185,308
154,344
98,382
Cost of Revenue
74,923
75,553
57,909
49,301
22,530
Gross Profit
99,579
94,723
127,399
105,043
75,852
Operating Expenses
Research Development
119,761
122,117
141,756
142,343
116,072
Selling General and Administrative
171,290
172,513
184,130
169,967
110,894
Total Operating Expenses
292,754
296,329
327,585
314,009
228,669
Operating Income or Loss
-193,175
-201,606
-200,186
-208,966
-152,817
Interest Expense
13,262
13,800
4,238
0
-
Total Other Income/Expenses Net
-
-25,429
-
-
-
Income Before Tax
-215,137
-225,304
-200,368
-207,298
-146,227
Income from Continuing Operations
-215,137
-225,304
-200,368
-207,298
-146,227
Net Income
-215,058
-225,250
-200,191
-207,279
-146,227
Net Income available to common shareholders
-215,058
-225,250
-200,191
-207,279
-146,227
Basic EPS
-1.40
-1.56
-1.40
-1.48
-1.11
Diluted EPS
-1.40
-1.56
-1.40
-1.48
-1.11
Basic Average Shares
142,516
144,383
142,516
140,355
131,216
Diluted Average Shares
142,516
144,383
142,516
140,355
131,216
Data Disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy Dashboard
About Our Ads
© 2024 Yahoo. All rights reserved.